Sprague-Dawley rats, 4 weeks old males, were used in groups of four, totaling 32 individuals. Diabetes was induced using Streptozocin at a dosage of 70 mg/kg, with implants placed 28 days prior to induction. The type of diabetes modeled was T1DM, managed with insulin medication. The induction of diabetes occurred 28 days after implant placement. The gene discussed is INS; the disease is type 1 diabetes mellitus.